Read More Analyst Ratings Downgrades Markets News Trading Ideas This Texas Instruments Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Today By Avi Kapoor May 13, 9:06 AM Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst… AGS
Read More FDA News Cabaletta Bio To Present Data At 31st EADV Congress And Provides Update On DesCAARTes Trial By Benzinga Newsdesk August 29, 2:04 PM abaletta Bio, Inc. (NASDAQ:CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients with autoimmune diseases, today announced that it will present new CABA
Read More Analyst Ratings News Price Target Citigroup Maintains Buy on National Vision Holdings, Raises Price Target to $48 By Benzinga Newsdesk November 15, 8:22 AM Citigroup analyst Paul Lejuez maintains National Vision Holdings (NASDAQ:EYE) with a Buy and raises the price target from $41 to $48. EYE
Read More Analyst Ratings Initiation News Price Target RBC Capital Initiates Coverage On Mobileye Global with Outperform Rating, Announces Price Target of $41 By Benzinga Newsdesk November 21, 8:23 AM RBC Capital analyst Joseph Spak initiates coverage on Mobileye Global (NASDAQ:MBLY) with a Outperform rating and announces Price Target of $41. MBLY